This is Mind Cure's third high-profile addition to its Scientific Advisory Board in the last week.
This is Mind Cure's third high-profile addition to its Scientific Advisory Board in the last week.
The mental healthcare industry is ripe for innovation. And companies like Mind Cure (CSE: MCUR), which recently completed its IPO, are set to lead the way.
Mind Cure's latest addition to its Scientific Advisory Board is a noted expert in psychedelic medicine, published researcher, and professor of pharmacology.
Mind Cure adds a thought leader in the psychedelics space to its Advisory Board.
Noted psychedelic drug expert, Hamilton Morris, is the latest addition to Mind Cure's advisory board.
Dr. Dan Engle, a leading voice in psychedelic medicine, has been appointed by Mind Cure (CSE:MCUR) as a scientific advisor
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now